TSXV:BRM

Stock Analysis Report

Executive Summary

BIOREM Inc., an environmental biotechnology company, designs, manufactures, and sells air emissions control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs) in Canada, the United States, China, and internationally.

Snowflake

Fundamentals

Flawless balance sheet with solid track record.

Share Price & News

How has BIOREM's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

1.5%

BRM

1.6%

CA Commercial Services

0.2%

CA Market


1 Year Return

-9.3%

BRM

-10.9%

CA Commercial Services

3.5%

CA Market

Return vs Industry: BRM exceeded the Canadian Commercial Services industry which returned -10.9% over the past year.

Return vs Market: BRM underperformed the Canadian Market which returned 3.5% over the past year.


Shareholder returns

BRMIndustryMarket
7 Day1.5%1.6%0.2%
30 Day-2.9%-4.9%-3.3%
90 Day0%-4.5%-1.9%
1 Year-9.3%-9.3%-7.7%-10.9%7.3%3.5%
3 Year41.7%41.7%1.3%-6.8%14.7%4.4%
5 Year6.3%6.3%-18.2%-33.0%26.2%7.7%

Price Volatility Vs. Market

How volatile is BIOREM's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is BIOREM undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: BRM (CA$0.34) is trading below our estimate of fair value (CA$3.44)

Significantly Below Fair Value: BRM is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: BRM is good value based on its PE Ratio (2.8x) compared to the Commercial Services industry average (12.8x).

PE vs Market: BRM is good value based on its PE Ratio (2.8x) compared to the Canadian market (13.7x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BRM's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BRM is overvalued based on its PB Ratio (1x) compared to the CA Commercial Services industry average (0.8x).


Next Steps

Future Growth

How is BIOREM forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

-14.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BRM's earnings are forecast to decline over the next 3 years (-14.4% per year).

Earnings vs Market: BRM's earnings are forecast to decline over the next 3 years (-14.4% per year).

High Growth Earnings: BRM's earnings are forecast to decline over the next 3 years.

Revenue vs Market: Insufficient data to determine if BRM's revenue is forecast to grow faster than the Canadian market.

High Growth Revenue: Insufficient data to determine if BRM's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BRM's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has BIOREM performed over the past 5 years?

57.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: BRM has become profitable over the past 5 years, growing earnings by 57.7% per year.

Accelerating Growth: BRM's earnings growth over the past year (180.2%) exceeds its 5-year average (57.7% per year).

Earnings vs Industry: BRM earnings growth over the past year (180.2%) exceeded the Commercial Services industry -2.1%.


Return on Equity

High ROE: BRM's Return on Equity (37%) is considered high.


Return on Assets

ROA vs Industry: BRM has a higher Return on Assets than the Commercial Services industry average last year.


Return on Capital Employed

ROCE Improving: BRM's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is BIOREM's financial position?


Financial Position Analysis

Short Term Liabilities: BRM's short term assets (CA$17.2M) exceeds its short term liabilities (CA$7.7M)

Long Term Liabilities: BRM has no long term liabilities


Debt to Equity History and Analysis

Debt Level: BRM is debt free.

Reducing Debt: BRM currently has no debt however we can't compare to 5 years ago as we have no data for that period.

Debt Coverage: BRM has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: BRM has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: BRM has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if BRM's debt is covered by short term assets.


Next Steps

Dividend

What is BIOREM's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.0%markettop25%5.9%industryaverage1.6%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate BRM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate BRM's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if BRM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BRM's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BRM's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

What is the CEO of BIOREM's salary, the management and board of directors tenure and is there insider trading?

2.8yrs

Average board tenure


CEO

Derek Webb 0

4.8yrs

Tenure

CA$344,450

Compensation

Mr. Derek S. Webb, P.Eng., MBA has been the Chief Executive Officer and President of BIOREM Inc. since December 17, 2014. Mr. Webb served as Executive Vice President of BIOREM Inc. from January 2012 to De ...


CEO Compensation Analysis

Compensation vs. Market: Derek's total compensation ($USD263.23K) is about average for companies of similar size in the Canadian market ($USD135.83K).

Compensation vs Earnings: Derek's compensation has been consistent with company performance over the past year.


Board Age and Tenure

2.8yrs

Average Tenure

Experienced Board: BRM's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: BRM insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellCA$4,32016 Sep 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares12,000
Max PriceCA$0.36
SellCA$72012 Sep 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares2,000
Max PriceCA$0.36
SellCA$9,02115 Jul 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares26,000
Max PriceCA$0.35
SellCA$3,60008 Jul 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares10,000
Max PriceCA$0.36
SellCA$12,22405 Jul 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares35,000
Max PriceCA$0.35
SellCA$17,50002 Jul 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares50,000
Max PriceCA$0.35
SellCA$16,53227 Jun 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares47,000
Max PriceCA$0.36
SellCA$2,52924 Jun 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares7,000
Max PriceCA$0.37
SellCA$7,40020 Jun 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares20,000
Max PriceCA$0.37
SellCA$8,75017 Jun 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares25,000
Max PriceCA$0.35
SellCA$7,20013 Jun 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares20,000
Max PriceCA$0.36
SellCA$3,50011 Jun 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares10,000
Max PriceCA$0.35
SellCA$7,00004 Jun 19
Brian Herner
EntityIndividual
Role
Member of the Board of Directors
Director
Shares20,000
Max PriceCA$0.35

Ownership Breakdown


Management Team

  • Derek Webb

    CEO, President & Director

    • Tenure: 4.8yrs
    • Compensation: CA$344.45k
  • Doug Newman

    CFO & Secretary

    • Tenure: 7.6yrs
    • Compensation: CA$205.40k

Board Members

  • Brian Herner

    Director

    • Tenure: 4.8yrs
    • Compensation: CA$24.65k
  • Qingjie Zhao (61yo)

    Chairman

    • Tenure: 2.8yrs
    • Compensation: CA$33.95k
  • Derek Webb

    CEO, President & Director

    • Tenure: 4.8yrs
    • Compensation: CA$344.45k
  • P. Ennis

    Director

    • Tenure: 2.9yrs
    • Compensation: CA$27.15k
  • Ken Chen

    Director

    • Tenure: 0.6yrs
  • Vivian Yuan

    Director

    • Tenure: 0.2yrs

Company Information

BIOREM Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: BIOREM Inc.
  • Ticker: BRM
  • Exchange: TSXV
  • Founded:
  • Industry: Environmental and Facilities Services
  • Sector: Commercial Services
  • Market Cap: CA$13.145m
  • Shares outstanding: 38.66m
  • Website: https://www.biorem.biz

Location

  • BIOREM Inc.
  • 7496 Wellington Road 34
  • Guelph
  • Ontario
  • N1H 6H9
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BRMTSXV (TSX Venture Exchange)YesCommon SharesCACADJan 2005
BIRM.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJan 2005

Biography

BIOREM Inc., an environmental biotechnology company, designs, manufactures, and sells air emissions control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air po ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/22 23:54
End of Day Share Price2019/10/21 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.